Aristotle Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14M | Sell |
64,146
-1,821
| -3% | -$404K | 0.03% | 127 |
|
|
2025
Q4 | $15.1M | Buy |
65,967
+43
| +0.1% | +$9.79K | 0.03% | 127 |
|
|
2025
Q3 | $15.3M | Sell |
65,924
-983
| -1% | -$200K | 0.03% | 130 |
|
|
2025
Q2 | $12.4M | Sell |
66,907
-75
| -0.1% | -$13.9K | 0.02% | 128 |
|
|
2025
Q1 | $14M | Buy |
66,982
+367
| +0.6% | +$71.3K | 0.03% | 124 |
|
|
2024
Q4 | $11.8M | Sell |
66,615
-2,040
| -3% | -$375K | 0.02% | 131 |
|
|
2024
Q3 | $13.6M | Hold |
68,655
| – | – | 0.02% | 130 |
|
|
2024
Q2 | $11.8M | Sell |
68,655
-73,248
| -52% | -$12.1M | 0.02% | 127 |
|
|
2024
Q1 | $25.8M | Buy |
141,903
+144
| +0.1% | +$24.8K | 0.05% | 121 |
|
|
2023
Q4 | $22M | Buy |
141,759
+73,800
| +109% | +$10.8M | 0.04% | 119 |
|
|
2023
Q3 | $10.1M | Sell |
67,959
-1,020
| -1% | -$150K | 0.02% | 123 |
|
|
2023
Q2 | $9.29M | Sell |
68,979
-6,815
| -9% | -$999K | 0.02% | 124 |
|
|
2023
Q1 | $12.1M | Sell |
75,794
-8,168
| -10% | -$1.25M | 0.03% | 120 |
|
|
2022
Q4 | $13.6M | Buy |
83,962
+8,579
| +11% | +$1.32M | 0.03% | 121 |
|
|
2022
Q3 | $10.1M | Buy |
75,383
+187
| +0.2% | +$26.8K | 0.02% | 122 |
|
|
2022
Q2 | $11.5M | Sell |
75,196
-104
| -0.1% | -$15.9K | 0.02% | 122 |
|
|
2022
Q1 | $12.2M | Sell |
75,300
-100
| -0.1% | -$14.5K | 0.02% | 124 |
|
|
2021
Q4 | $10.2M | Buy |
75,400
+11
| +0% | +$1.3K | 0.02% | 128 |
|
|
2021
Q3 | $8.13M | Buy |
75,389
+112
| +0.1% | +$12.8K | 0.02% | 125 |
|
|
2021
Q2 | $8.48M | Sell |
75,277
-1,200
| -2% | -$135K | 0.02% | 126 |
|
|
2021
Q1 | $8.28M | Sell |
76,477
-103
| -0.1% | -$11K | 0.02% | 124 |
|
|
2020
Q4 | $8.21M | Sell |
76,580
-14
| -0% | -$1.34K | 0.02% | 126 |
|
|
2020
Q3 | $6.71M | Buy |
76,594
+9
| +0% | +$847 | 0.02% | 121 |
|
|
2020
Q2 | $7.52M | Buy |
76,585
+1
| +0% | +$88 | 0.03% | 112 |
|
|
2020
Q1 | $5.83M | Sell |
76,584
-2,780
| -4% | -$237K | 0.02% | 116 |
|
|
2019
Q4 | $7.03M | Sell |
79,364
-15
| -0% | -$1.25K | 0.02% | 115 |
|
|
2019
Q3 | $6.01M | Sell |
79,379
-4,262
| -5% | -$292K | 0.03% | 116 |
|
|
2019
Q2 | $6.08M | Sell |
83,641
-635,257
| -88% | -$49.9M | 0.03% | 111 |
|
|
2019
Q1 | $57.9M | Sell |
718,898
-2,325,371
| -76% | -$190M | 0.34% | 47 |
|
|
2018
Q4 | $281M | Sell |
3,044,269
-430,667
| -12% | -$37.9M | 1.89% | 29 |
|
|
2018
Q3 | $329M | Sell |
3,474,936
-649,633
| -16% | -$61.6M | 1.91% | 28 |
|
|
2018
Q2 | $382M | Buy |
4,124,569
+336,696
| +9% | +$32.9M | 2.35% | 17 |
|
|
2018
Q1 | $359M | Buy |
3,787,873
+34,727
| +0.9% | +$3.81M | 2.41% | 17 |
|
|
2017
Q4 | $363M | Sell |
3,753,146
-879,600
| -19% | -$82.9M | 2.52% | 14 |
|
|
2017
Q3 | $412M | Buy |
4,632,746
+3,854
| +0.1% | +$293K | 3.2% | 3 |
|
|
2017
Q2 | $336M | Buy |
4,628,892
+102,269
| +2% | +$6.88M | 2.8% | 9 |
|
|
2017
Q1 | $295M | Buy |
4,526,623
+154,719
| +4% | +$9.73M | 2.68% | 12 |
|
|
2016
Q4 | $274M | Buy |
4,371,904
+176,116
| +4% | +$10.8M | 2.59% | 13 |
|
|
2016
Q3 | $265M | Sell |
4,195,788
-48,523
| -1% | -$3.14M | 2.75% | 9 |
|
|
2016
Q2 | $263M | Buy |
4,244,311
+89,306
| +2% | +$5.44M | 2.85% | 8 |
|
|
2016
Q1 | $237M | Buy |
4,155,005
+133,367
| +3% | +$7.43M | 2.75% | 12 |
|
|
2015
Q4 | $238M | Buy |
4,021,638
+140,989
| +4% | +$8.12M | 2.87% | 9 |
|
|
2015
Q3 | $211M | Buy |
3,880,649
+163,173
| +4% | +$10.6M | 2.64% | 11 |
|
|
2015
Q2 | $250M | Sell |
3,717,476
-36,110
| -1% | -$2.36M | 2.94% | 6 |
|
|
2015
Q1 | $220M | Buy |
3,753,586
+196,282
| +6% | +$11.9M | 2.73% | 8 |
|
|
2014
Q4 | $233M | Sell |
3,557,304
-24,455
| -0.7% | -$1.54M | 2.98% | 5 |
|
|
2014
Q3 | $207M | Buy |
3,581,759
+173,512
| +5% | +$9.63M | 2.72% | 7 |
|
|
2014
Q2 | $192M | Buy |
3,408,247
+163,734
| +5% | +$8.59M | 2.56% | 8 |
|
|
2014
Q1 | $167M | Buy |
3,244,513
+127,372
| +4% | +$6.44M | 2.42% | 14 |
|
|
2013
Q4 | $165M | Buy |
3,117,141
+734,991
| +31% | +$36.1M | 2.62% | 8 |
|
|
2013
Q3 | $107M | Buy |
2,382,150
+525,610
| +28% | +$23.3M | 2.13% | 22 |
|
|
2013
Q2 | $76.7M | Buy |
+1,856,540
| New | +$81.2M | 2.11% | 23 |
|
Other funds holding ABBV
VCM
VPM
Aristotle Capital Management's ABBV Position: Q1 2026 in Review
Aristotle Capital Management reduced its AbbVie (ABBV) stake by 2.8% in Q1 2026, selling an estimated $404K and leaving 64,146 shares worth $14M. The position accounts for 0.03% of the portfolio, ranked #127.
Aristotle Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $412M in Q3 2017. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Aristotle Capital Management held 64,146 shares of AbbVie worth $14M as of Q1 2026.
- Aristotle Capital Management sold 1,821 AbbVie shares in Q1 2026, an estimated $404K.
- AbbVie made up 0.03% of Aristotle Capital Management's portfolio in Q1 2026, its #127 holding.
- Aristotle Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Aristotle Capital Management's AbbVie position peaked at $412M in Q3 2017.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Aristotle Capital Management's 13F filing for Q1 2026, filed 15 May 2026.